Actively Recruiting
Relationship About Pregnancy Health and Offspring Developmental &Behavioral Outcomes
Led by Chen Li · Updated on 2021-02-01
3000
Participants Needed
5
Research Sites
495 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This topic puts forward a hypothesis: genetic and environmental factors such as major depressive disorder during pregnancy, nutritional status of vitamin A, D, E, and folic acid, intestinal microecology, and bisphenol A exposure, may affect the cognitive development level of the offspring through the genetic correlation with attention deficit hyperactivity disorder, developmental delay/intellectual disability, and major depressive disorder, allelic heterogeneity and pleiotropy of ITIH3 mediated by SNP and CACNB2, neurotransmitters like dopamine, and metabolic pathways, thereby increasing the risk of attention deficit hyperactivity disorder and developmental delay/intellectual disability prevalence on offspring. This topic planning from allelic heterogeneity and pleiotropy of attention deficit hyperactivity disorder and major depressive disorder mediated by SNP, neurotransmitters like dopamine, and metabolic pathways, explores deeply the influences on children's development level and the risk of common neurological disorder caused by genetic and environmental factors during pregnancy, looking for reasonable prevention, early diagnosis of biomarkers and therapeutic targets, in order to provide data support for further improvement and revision of national mother and infant healthcare policy .
CONDITIONS
Official Title
Relationship About Pregnancy Health and Offspring Developmental &Behavioral Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women aged 20 to 49 years
- No cognitive impairment and able to complete scale tests
- Hamilton Depression Scale score less than 8 or mild to moderate depression (score 8 to 35)
- Provided written informed consent to participate in the study
You will not qualify if you...
- Received anti-depression therapy during the first 6 months of pregnancy or during pregnancy
- Severe depression with Hamilton Depression Scale score of 35 or higher
- Diagnosed with other mental disorders
- Diagnosed with neurological diseases
- Have cognitive dysfunction
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
The People's Hospital of Yubei District of Chongqing City
Chongqing, Chongqing Municipality, China, 401120
Not Yet Recruiting
2
Chongqing First People's Hospital of Liangjiang New Area
Chongqing, Chongqing Municipality, China, 401121
Not Yet Recruiting
3
The Central Hospital of Jiangjin District of Chongqing City
Chongqing, Chongqing Municipality, China, 402260
Not Yet Recruiting
4
Wanzhou Health Center for Women and Children
Chongqing, Chongqing Municipality, China, 404100
Actively Recruiting
5
The Maternal and Child Health Hospital of Hainan Province
Haikou, Hainan, China, 570000
Not Yet Recruiting
Research Team
L
Li Chen, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here